the results have been compared with afp levels in psoriatics without puva treatment ( group ii ) , patients with psoriatic arthritis treated with methotrexate ( group iii ) , as well as dermatological patients without psoriasis ( group iv ) .
C0025677
methotrexate
C0033860
psoriasis